Showing results (1531-1540 of 3,190) with videos related to

Sort By:
Pageof 319
Translational Oncology|April 24, 2026
Toxicarioside H induces cytoprotective autophagy by hindering the progression of necroptosis in triple-negative breast cancer cellsWei Xiong, Guang-Hong Tan, Hengyu Chen, et al.
Translational Oncology|April 22, 2026
Exercise reshapes gut microbiota function to enhance cancer therapyWen Fang, Yang Wu, Zhenyu Yang, et al.
Translational Oncology|April 7, 2026
Single-cell transcriptome analysis indicated that immune-related programmed cell death modification features could predict the clinical outcomes of patients with ovarian cancerJieyun Sun, Li Jing, Xiangfei Zhu, et al.
Translational Oncology|April 7, 2026
CD38 overexpression drives glioblastoma progression via L1CAM/ICAM1/JAK-STAT-Driven tumor microenvironment rewiringSaeed Norouzi, Sonikpreet Aulakh
Translational Oncology|April 15, 2026
Integrated spatial and single‑cell transcriptomics maps disulfidptosis in renal cell carcinoma and reveals PDLIM1 as a prognostic biomarker and potential therapeutic targetWenqiang Liu, Xianglin Liu, Juan Yi, et al.
Translational Oncology|April 15, 2026
Identification of MYC co-expression gene: POLR3G is associated with cell senescence, immunotherapy, chemotherapy responses, and clinical prognosis in bladder cancer patientsLi Zhu, Yang Liu, Jianjun Lan, et al.
Translational Oncology|August 11, 2026
A multimodal radiomics, deep learning, and pathomics signature for predicting the prognosis in central conventional chondrosarcomaQiushi Su, Jie Wu, Ben Li, et al.
Translational Oncology|August 17, 2026
Identification of a three-gene prognostic signature associated with tumor immune characteristics in lung adenocarcinoma: A comprehensive analysis of multi-omics dataHuangkai Zhu, Yanna Fang, Minglei Yang, et al.
Translational Oncology|August 15, 2026
Integration of single-cell transcriptomics and genomic mutation analysis identifies an immunotherapy-resistant tumor subcluster and validates ARNTL2 as a malignant driver in lung adenocarcinomaZhengang Qiu, Hui Zhao, Qiong Lyu, et al.
Translational Oncology|August 20, 2026
Clostridium Butyricum and butyrate enhance PD-1 inhibitor therapy in non-small cell lung cancer by regulating the HDAC1/ID2/IL-12R pathwayZhuo Chen, Meng-Lei Wang, Zhuo-Wen Zhang, et al.
Pageof 319